Citation Impact

Citing Papers

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Abnormal mitral valve coaptation in hypertrophic obstructive cardiomyopathy: Proposed role in systolic anterior motion of mitral valve
1981
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Pathological considerations in replacement cardiac valves
1992
Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole.
1991
A decision aid for referring patients with systolic murmurs for echocardiography
1994
Calcification of the Mitral Valve and Annulus: Systematic Evaluation of Effects on Valve Anatomy and Function
2013
Noninvasive assessment of left ventricular diastolic function by pulsed doppler echocardiography in patients with hypertrophic cardiomyopathy
1987
The Duration of Hypotension before the Initiation of Antibiotic Treatment Is a Critical Determinant of Survival in a Murine Model ofEscherichia coliSeptic Shock: Association with Serum Lactate and Inflammatory Cytokine Levels
2005
Mechanisms of exercise limitation in hypertrophic cardiomyopathy
1992
Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study
1994
Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy
1990
Pulsed Doppler Characterization of Left Atrial Appendage Flow
1993
Hypertrophic cardiomyopathy: current understanding and treatment objectives
2008
Patent Foramen Ovale
2012
Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
2007
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
2013 Standout
Transesophageal echocardiographic detection of atrial thrombi in patients with nonfibrillation atrial tachyarrhythmias and congenital heart disease
1994
Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death
2002
Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: Clarification of pathophysiology and importance in intraoperative decision making
1992
Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction
2003
Time to Treatment and Mortality during Mandated Emergency Care for Sepsis
2017 Standout
Survival of Cardiac Arrest after Aneurysmal Subarachnoid Hemorrhage
2005
Hemodynamic and clinical impact of prosthesis–patient mismatch in the aortic valve position and its prevention
2000
Exercise Standards for Testing and Training
2013 Standout
Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy
2006
Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy
1995
Noninvasive Imaging in Myocarditis
2006
Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
1995
Assessment of Left Atrial Appendage Structure and Function by Transesophageal Echocardiography
1998
Late results of mitral valve repair for mitral regurgitation due to degenerative disease
1993
The 50-Year History, Controversy, and Clinical Implications of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
2009
Pathophysiologic Correlates of Thromboembolism in Nonvalvular Atrial Fibrillation: II. Dense Spontaneous Echocardiographic Contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] Study)
1999
Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC)
2008
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Left Ventricular Rupture Associated With Takotsubo Cardiomyopathy
2004
Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment
2007
Myocardial dysfunction associated with brain death: clinical, echocardiographic, and pathologic features
2001
Elderly patients with hypertrophic cardiomyopathy: A subset with distinctive left ventricular morphology and progressive clinical course late in life
1989
Relation between extent of left ventricular hypertrophy and age in hypertrophic cardiomyopathy
1989
Clinical Course and Prognosis of Hypertrophic Cardiomyopathy in an Outpatient Population
1989
An echocardiographic study of the fluid machanics of obstruction in hypertrophic cardiomyopathy
1993
Are stentless valves hemodynamically superior to stented valves? A prospective randomized trial
2002
Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients
1995
Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future
2008
Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy
1993
A cohort study of childhood hypertrophic cardiomyopathy
1999
Left Atrial Appendage Flow Velocity as a Quantitative Surrogate Parameter for Thromboembolic Risk: Determinants and Relationship to Spontaneous Echocontrast and Thrombus Formation–A Transesophageal Echocardiographic Study in 500 Patients with Cerebral Ischemia
2005
Hypertrophic cardiomyopathy
1994
Transthoracic Echocardiographic Predictors of Left Atrial Appendage Thrombus
2005
Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy
1990
Recurrent Cerebrovascular Events Associated with Patent Foramen Ovale, Atrial Septal Aneurysm, or Both
2001 Standout
Electrocardiographic Changes in Patients with Acute Stroke: A Systematic Review
2002
Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy
1996
Myocarditis
2011 Standout
The clinical features of takotsubo cardiomyopathy
2003
Diagnostic, Prognostic, and Therapeutic Implications of Genetic Testing for Hypertrophic Cardiomyopathy
2009
An Association Between QTc Prolongation and Left Ventricular Hypokinesis During Sequential Episodes of Subarachnoid Hemorrhage
1999
Role of left atrial appendageobliteration in stroke reductionin patients with mitral valve prosthesis
2003
Incidence of left atrial thrombi in patients in sinus rhythm and with a recent neurologic deficit
2000
Clinical and morphologic expression of hypertrophic cardiomyopathy in patients ≥ 65 years of age
1994
Coexistence of mitral valve prolapse in a consecutive group of 528 patients with hypertrophic cardiomyopathy assessed with echocardiography
1992
Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart.
1998
Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium
2004 StandoutNature
Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy
1992
A Syndrome of Transient Left Ventricular Apical Wall Motion Abnormality in the Absence of Coronary Disease: A Perspective from the United States
2003
Utility of continuous wave doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy
1992
Long-term results of mitral valve repair for myxomatous disease with and without chordal replacement with expanded polytetrafluoroethylene sutures
1998
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Clinical characteristics and Thrombolysis In Myocardial Infarction frame counts in women with transient left ventricular apical ballooning syndrome
2004
Echocardiographic “smoke” is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces
1992
Cardiac Myxomas
1995 Standout
Hypertrophic Cardiomyopathy
2002 Standout
Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy
1999
The Management of Hypertrophic Cardiomyopathy
1997
Subarachnoid haemorrhage
2007 Standout
Survival advantage of stentless aortic bioprostheses
2000
Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy
2005
Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy
2000
Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis
2016
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
2005 Standout
Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage
2001
Reversible Myocardial Contraction Abnormalities in Patients With an Acute Noncardiac Illness
1998
Aortic Valve Replacement With the Freestyle Stentless Bioprosthesis : Five-Year Experience
1999
Regional Patterns of Left Ventricular Systolic Dysfunction After Subarachnoid Hemorrhage: Evidence for Neurally Mediated Cardiac Injury
2000
Transcatheter closure of patent foramen ovale in older adults
2006
Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins
1998 Standout
Platelet-derived growth factor plays a critical role to convert bone marrow cells into glomerular mesangial-like cells
2003 StandoutNobel
Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: Neurogenic stunned myocardium
1994
Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy during childhood
1989
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy
1993
Recovery of atrial function after atrial compartment operation for chronic atrial fibrillation in mitral valve disease
1994
Transesophageal Doppler color flow mapping assessment of atrial septal defect
1990
The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events
2000
Development and determinants of dynamic obstruction to left ventricular outflow in young patients with hypertrophic cardiomyopathy.
1992
Hypertrophic Cardiomyopathy
1995
Body surface distribution of abnormally low QRST areas in patients with left ventricular hypertrophy. An index of repolarization abnormalities.
1991 StandoutNobel
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice
1998 StandoutNobel
[Tako-tsubo-like transient left ventricular dysfunction with apical thrombus formation: a case report].
2004
Systematic Review: Transient Left Ventricular Apical Ballooning: A Syndrome That Mimics ST-Segment Elevation Myocardial Infarction
2004 Standout
Hypertrophic obstructive cardiomyopathy: Preoperative echocardiographic predictors of outcome after septal myectomy
1996
Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review
1985
Magnesium in Man: Implications for Health and Disease
2014 Standout
Left Ventricular Rupture Associated With Takotsubo Cardiomyopathy
2004
Has 'obstruction' hindered our understanding of hypertrophic cardiomyopathy?
1985
Morphologic determinants of hemodynamic state after ventricular septal myotomy-myectomy in patients with obstructive hypertrophic cardiomyopathy: M mode and two-dimensional echocardiographic assessment.
1984
Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features
1981
Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans
2002 Standout
Reproducibility of left ventricular volumes by two-dimensional echocardiography
1983
Patterns of inheritance in hypertrophic cardiomyopathy: Assessment by m-mode and two-dimensional echocardiography
1984
Current operative treatment of obstructive hypertrophic cardiomyopathy.
1988
123I-MIBG myocardial scintigraphy in patients with "takotsubo" cardiomyopathy.
2004
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Echo-Doppler and Color-Flow Imaging in Congenital Heart Disease
1990
Obstruction is unimportant in the pathophysiology of hypertrophic cardiomyopathy
1986
Transthoracic Echocardiography in Models of Cardiac Disease in the Mouse
1996
Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation.
1997
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Mobilized bone marrow cells repair the infarcted heart, improving function and survival
2001 Standout
Echocardiographic Assessment of Spontaneously Occurring Feline Hypertrophic Cardiomyopathy
1995
Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy
1998
Myocardial Injury and Left Ventricular Performance After Subarachnoid Hemorrhage
1999
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Spontaneous Variability of Left Ventricular Outflow Tract Gradient in Hypertrophic Obstructive Cardiomyopathy
1998
Task force 3: Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse
1994
Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy
1988
Clinical and echocardiographic features of right atrial masses
1984
Sudden Cardiac Death
1998 Standout
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
1997 StandoutNobel
Pitfalls in Clinical Recognition and a Novel Operative Approach for Hypertrophic Cardiomyopathy With Severe Outflow Obstruction Due to Anomalous Papillary Muscle
1998
Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery11Supported, in part, by grant NCC9-60 from the National Aeronautics and Space Administration, Houston, Texas, Grant #9951522V from the America Heart Association Ohio Local Chapter, Columbus, Ohio and Grant #R01 HL56688-01A1 from the National Institutes of Health, Bethesda, Maryland.22Presented, in part, at the 49th Annual Scientific Sessions of American College of Cardiology, March 2000, Anaheim, California.
2001
Angiotensin II Type 2 Receptor Is Essential for Left Ventricular Hypertrophy and Cardiac Fibrosis in Chronic Angiotensin II–Induced Hypertension
2001
Echocardiographic assessment of mitral valve size in obstructive hypertrophic cardiomyopathy. Anatomic validation from mitral valve specimen.
1993
Mechanism of Benefit of Negative Inotropes in Obstructive Hypertrophic Cardiomyopathy
1998
Patterns of systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: Assessment by two-dimensional echocardiography
1984
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)
2002 Standout
Left Atrial Dysfunction in Patients With Atrial Fibrillation After Successful Rhythm Control for > 3 Months
2005
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
1989 Standout
Development and Progression of Left Ventricular Hypertrophy in Children with Hypertrophic Cardiomyopathy
1986
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies
1996 Standout
Apical Hypertrophic Cardiomyopathy: Clinical and Two-Dimensional Echocardiographic Assessment
1987
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy
1987
Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy
1986
Third-Generation Biomedical Materials
2002 StandoutScience
Uses and limitations of transthoracic echocardiography in the assessment of atrial septal defect in the adult
1991
Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction
2003 Standout
Electrocardiographic Abnormalities and Serum Magnesium in Patients With Subarachnoid Hemorrhage
2004
Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults
1995 Standout
Systolic anterior motion of the posterior mitral leaflet: a previously unrecognized cause of dynamic subaortic obstruction in patients with hypertrophic cardiomyopathy.
1983
Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.
1992
Regional left ventricular asynchrony and impaired global left ventricular filling in hypertrophic cardiomyopathy: Effect of verapamil
1987
Diastolic abnormalities in patients with hypertrophic cardiomyopathy: relation to magnitude of left ventricular hypertrophy.
1985
Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients
2000
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia.
1994
CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
1999 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.
1985
Hypertrophic Cardiomyopathy
1987
Late Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease
2013
Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: Functional and morphologic features and clinical significance
1986
Acute and Reversible Cardiomyopathy Provoked by Stress in Women From the United States
2005 Standout
An Association Between QTc Prolongation and Left Ventricular Hypokinesis During Sequential Episodes of Subarachnoid Hemorrhage
1999
Increased Pelvic Vein Thrombi in Cryptogenic Stroke
2003
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Management of Symptoms in Hypertrophic Cardiomyopathy
2008
Morphological determinants of echocardiographic patterns of mitral valve systolic anterior motion in obstructive hypertrophic cardiomyopathy.
1993
Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy
1986
Coronary Microvascular Abnormality in the Reversible Systolic Dysfunction Observed After Noncardiac Disease
2000
Infective Endocarditis in Hypertrophic Cardiomyopathy
1999
Heterogeneous morphologic expression of genetically transmitted hypertrophic cardiomyopathy. Two-dimensional echocardiographic analysis.
1983
Surgical intervention and support for cardiomyopathies of childhood
1992
Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction
2006
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011

Works of Charles Pollick being referenced

Acute myocarditis presenting as asymmetric septal hypertrophy.
1989
Disopyramide in hypertrophic cardiomyopathy II. Noninvasive assessment after oral administration
1988
Incomplete Left Atrial Appendage Ligation that Simulates Mitral Regurgitation
1990
Left Ventricular Wall Motion Abnormalities in Subarachnoid Hemorrhage: An Echocardiographic Study
1988
Femoral vein delivery of contrast medium enhances transthoracic echocardiographic detection of patent foramen ovale
1993
Echocardiographic and cardiac doppler assessment of mice
1995
Disopyramide in hypertrophic cardiomyopathy I. Hemodynamic assessment after intravenous administration
1988
Isolated Thickening of One Aortic Cusp: Preferential Thickening of the Noncoronary Cusp
1988
Mitral valve annuloplasty: The effect of the type on left ventricular function
1989
The cardiac effects of d- and l-disopyramide in normal subjects: a noninvasive study.
1982
Colour flow imaging in severe mitral and aortic regurgitation.
1988
Echocardiography in a district general hospital
1978
Two-dimensional echocardiographic detection of right atrial tumors
1982
Variability of digitized echocardiography: Size, source, and means of reduction
1983
Obstructive versus non-obstructive sam: A crucial distinction
1980
Doppler color-flow imaging assessment of shunt size in atrial septal defect.
1988
Muscular Subaortic Stenosis
1982
Hypertrophic cardiomyopathy: Subclassification by M mode echocardiography
1980
Assessment of left atrial appendage function by transesophageal echocardiography. Implications for the development of thrombus.
1991
Aortic valve replacement with stentless porcine aortic bioprosthesis
1990
Muscular subaortic stenosis: the temporal relationship between systolic anterior motion of the anterior mitral leaflet and the pressure gradient.
1982
Muscular subaortic stenosis: the quantitative relationship between systolic anterior motion and the pressure gradient.
1984
Dobutamine stress echocardiography: initial experience of a Canadian centre.
1992
Rankless by CCL
2026